7-Ketocholesterol Accelerates Pancreatic -Cell Senescence by Inhibiting the SIRT1/CDK4-Rb-E2F1 Signaling Pathway

Qiuping Zhu,Wei Wang,Nan Wu,Sunyue He,Xihua Lin,Wenjing Zhang,Jiaqiang Zhou
DOI: https://doi.org/10.1080/19382014.2023.2219105
2023-01-01
Islets
Abstract:Pancreatic beta-cell dysfunction is a key factor in the development of type 2 diabetes. Pancreatic beta-cell senescence accelerates abnormal glucose metabolism, which decreases insulin secretion and cell regeneration ability, eventually leading to diabetes. A cholesterol oxidation product, 7-ketocholesterol (7-KC) can affect pancreatic beta-cell function. However, its role in pancreatic beta-cell senescence has not been reported. We investigated the role of 7-KC in pancreatic beta-cell senescence and its underlying molecular mechanism in MIN6 cells. MIN6 cells were treated with 25 mu mol/L 7-KC for 24 h and the proportion of senescent cells was detected based on senescence-associated beta-galactosidase (SA-beta-gal) activity. The cell cycle, DNA damage, and the senescence-associate secretory phenotype (SASP) and protein expression were detected by flow cytometry, immunofluorescence, and western blotting, respectively. 7-KC can significantly increase SA-beta-gal activity, promoted G0/G1 arrest, DNA damage, and interleukin-1 beta expression in MIN6 cells and significantly inhibited insulin synthesis. Further studies indicated that 7-KC induced beta-cell senescence by inhibiting the SIRT1/CDK4-Rb - E2F1 signaling pathway. [GRAPHICS]
What problem does this paper attempt to address?